The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

Supportive Care in Cancer

Volumn 21, Issue 4, 2013, Pages 1185-1192

  Barton, Debra L ^a   Burger, Kelli ^a   Novotny, Paul J ^a   Fitch, Tom R ^b   Kohli, Sadhna ^a   Soori, Gamini ^c   Wilwerding, Mary Beth ^c   Sloan, Jeff A ^a   Kottschade, Lisa A ^a   Rowland Jr , Kendrith M ^d   Dakhil, Shaker R ^e   Nikcevich, Daniel A ^f   Loprinzi, Charles L ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

^c MISSOURI VALLEY CANCER CONSORTIUM   (United States)

^d Carle Cancer Center CCOP   (United States)

^e WICHITA COMMUNITY CLINICAL ONCOLOGY PROGRAM   (United States)

^f Duluth CCOP   (United States)

Author keywords

Adjuvant treatment; Breast cancer; Chemotherapy related cognitive dysfunction; Dietary supplements; Ginkgo biloba

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; GINKGO BILOBA EXTRACT; PLACEBO; TAXANE DERIVATIVE;

ADULT; ANEMIA; ARTICLE; BREAST CANCER; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GINKGO BILOBA; HIGH SENSITIVITY COGNITIVE SCREEN; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; OUTCOME ASSESSMENT; PERCEIVED HEALTH SCALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; SKIN BRUISING; THROMBOCYTOPENIA; TRAIL MAKING TEST A; TRAIL MAKING TEST B; VOMITING;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FEMALE; GINKGO BILOBA; HUMANS; MIDDLE AGED; PHYTOTHERAPY; SELF REPORT; UNITED STATES;

EID: 84879798958     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1647-9     Document Type: Article

References (40)

1. Huria A, Somlo G, Ahles T (2007) Renaming chemobrain. Cancer Investig 25:373-7
2. Pullens MJ, De Vries J, Roukema JA (2009) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology
3. Wieneke M, Dienst E (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 4:61-66
4. Brezden CB, Phillips KA, Abdolell M et al (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-701
5. Castellon SA, Ganz PA, Bower JE et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-69
6. Ferguson RJ, Ahles TA (2003) Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 3:215-22
7. Kreukels BP, van Dam FS, Ridderinkhof KR et al (2008) Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 8:80-7
8. Schagen SB, van Dam FS, Muller MJ et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-50
9. van Dam FS, Schagen SB, Muller MJ et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-8
10. Kohli S, Griggs J, Roscoe JA et al (2007) Self-reported cognitive impairment in cancer patients. J Oncol Pract
11. Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26:768-77
12. Janz NK, Mujahid M, Chung LK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16:1348-61
13. Mehnert A, Scherwath A, Schirmer L et al (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108-18
14. Mar Fan HG, Clemons M, Xu W et al (2008) A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16:577-83
15. Nelson CJ, Nandy N, Roth AJ (2007) Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care 5:273-80
16. Kohli S, Fisher SG, Tra Y et al (2009) The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115:2605-16
17. Le Bars PL, Katz MM, Berman N et al (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278:1327-32
18. Oken BS, Storzbach DM, Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55:1409-15
19. Natural Standard: Natural Standard Database
20. Schultz VHR, Tyler V (1998) Rational physotherapy: a physicians guide to herbal medicine, natural standard. Springer, New York, pp 38-49
21. Nada SE, Shah ZA (2012) Preconditioning with Ginkgo biloba (EGb 761(R)) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis 46:180-9
22. Smith JV, Luo Y (2004) Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 64:465-72
23. Faust D, Fogel BS (1989) The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25-31
24. Nelson A, Fogel BS, Faust D (1986) Bedside cognitive screening instruments. A critical assessment. J Nerv Ment Dis 174:73-83
25. Army Individual Test Battery (1944) Manual of direction and scoring. Washington, DC, War Department Adjutant General's Office
26. Fakouri C, Lyon B (2005) Perceived health and life satisfaction among older adults: the effects of worry and personal variables. J Gerontol Nurs 31:17-24
27. Barton D (2002) A model to predict negative health outcomes during cancer treatment
28. Dodge HH, Zitzelberger T, Oken BS et al (2008) A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 70:1809-17
29. Snitz BE, O'Meara ES, Carlson MC et al (2009) Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 302:2663-70
30. Solomon PR, Adams F, Silver A et al (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288:835-40
31. Kanowski S, Herrmann WM, Stephan K et al (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29:47-56
32. Donovan KA, Small BJ, Andrykowski MA et al (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499-507
33. Tannock IF, Ahles TA, Ganz PA et al (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233-9
34. Vardy J, Wong K, Yi QL et al (2006) Assessing cognitive function in cancer patients. Support Care Cancer 14:1111-8
35. Kibiger G, Kirsh KL, Wall JR et al (2003) My mind is as clear as it used to be: a pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer. J Pain Symptom Manage 26:705-15
36. Cull A, Hay C, Love SB et al (1996) What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 74:1674-9
37. Poppelreuter M, Weis J, Kulz AK et al (2004) Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 40:43-9
38. Ferguson RJ, McDonald BC, Saykin AJ et al (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866-70
39. McDonald BC, Conroy SK, Ahles TA et al (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123:819-28
40. Penttinen HM, Saarto T, Kellokumpu-Lehtinen P, et al (2010) Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psychooncology